Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence.
about
Hypovitaminosis D and "small burden" uterine fibroids: Opportunity for a vitamin D supplementation.Proliferation and ovarian hormone signaling are impaired in normal breast tissues from women with BRCA1 mutations: benefit of a progesterone receptor modulator treatment as a breast cancer preventive strategy in women with inherited BRCA1 mutations.Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids.
P2860
Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Clinical utility of ulipristal ...... ne fibroids: current evidence.
@ast
Clinical utility of ulipristal ...... ne fibroids: current evidence.
@en
type
label
Clinical utility of ulipristal ...... ne fibroids: current evidence.
@ast
Clinical utility of ulipristal ...... ne fibroids: current evidence.
@en
prefLabel
Clinical utility of ulipristal ...... ne fibroids: current evidence.
@ast
Clinical utility of ulipristal ...... ne fibroids: current evidence.
@en
P2093
P2860
P356
P1476
Clinical utility of ulipristal ...... ne fibroids: current evidence.
@en
P2093
Alice Trefoux Bourdet
Dominique Luton
Martin Koskas
P2860
P304
P356
10.2147/IJWH.S50016
P407
P577
2015-03-26T00:00:00Z